|
⚲
|
| Keyboard |
| del Carmen Jeffrey
✚
|
|
|---|---|
| CIK # | 0001816477 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001816477] | |
| 4 | [0001816477] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Catalyst Pharmaceuticals Inc | |
| del Carmen Jeffrey |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2025-12-29 | Tax withheld | 3,839 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2025-12-29 | Option exercise | 8,667 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2025-12-29 | Option exercise | 8,667 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2025-12-08 | Tax withheld | 2,492 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2025-12-08 | Option exercise | 8,039 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2025-12-08 | Option exercise | 8,039 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2025-11-26 | Option exercise | 10,983 | $4.21 | 46,238 |
|
Catalyst Pharmaceuticals Inc CPRX
Options to purchase common stock · derivative
|
2025-11-26 | Option exercise | 10,983 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2025-11-26 | Sell | 10,983 | $23.33 | 256,233 |
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2025-11-21 | Tax withheld | 1,641 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2025-11-21 | Option exercise | 5,603 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2025-11-21 | Option exercise | 5,603 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Options to purchase common stock · derivative
|
2025-11-20 | Grant | 106,873 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2025-11-20 | Grant | 32,257 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2025-03-03 | Sell | 30,423 | $22.89 | 696,382 |
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2025-02-14 | Option exercise | 10,667 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2025-02-14 | Option exercise | 10,667 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2025-02-14 | Tax withheld | 3,125 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2024-12-27 | Option exercise | 8,667 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2024-12-27 | Option exercise | 8,667 | ||
| showing 20 of 69 most recent transactions | |||||